Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Titel:
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Auteur:
Agarwal, Neeraj McGregor, Bradley Maughan, Benjamin L Dorff, Tanya B Kelly, William Fang, Bruno McKay, Rana R Singh, Parminder Pagliaro, Lance Dreicer, Robert Srinivas, Sandy Loriot, Yohann Vaishampayan, Ulka Goel, Sanjay Curran, Dominic Panneerselvam, Ashok Schwickart, Martin Choueiri, Toni K Pal, Sumanta